Posted Jul. 15, 2014 at 7:21 a.m.

Premium Lock GSK invests up to $25M in new drug manufacturing technology - in Pa., not N.C.

Published: 2014-07-15 07:21:19
Updated: 2014-07-15 07:21:19

GSK's R&D facility in RTP  GSK's R&D facility in RTP. (GSK photo)

GlaxoSmithKline, which operates a huge drug manufacturing facility in Zebulon, is investing as much as $25 million to license a technology platform from a California firm as part of efforts to develop new drugs. But GSK isn't bringing the platform to N.C., at least initially....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll